HK1255344A1 - Method for predicting prognosis and risk of developing hepatocellular carcinoma in liver cirrhosis patient - Google Patents

Method for predicting prognosis and risk of developing hepatocellular carcinoma in liver cirrhosis patient

Info

Publication number
HK1255344A1
HK1255344A1 HK18114481.7A HK18114481A HK1255344A1 HK 1255344 A1 HK1255344 A1 HK 1255344A1 HK 18114481 A HK18114481 A HK 18114481A HK 1255344 A1 HK1255344 A1 HK 1255344A1
Authority
HK
Hong Kong
Prior art keywords
risk
hepatocellular carcinoma
liver cirrhosis
predicting prognosis
cirrhosis patient
Prior art date
Application number
HK18114481.7A
Other languages
Chinese (zh)
Inventor
成松久
栂谷內晶
雄長誠
梶裕之
久野敦
佐藤隆
曾我部萬紀
千葉靖典
池原讓
田中靖人
飯尾悅子
Original Assignee
國立研究開發法人產業技術綜合研究所
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 國立研究開發法人產業技術綜合研究所 filed Critical 國立研究開發法人產業技術綜合研究所
Publication of HK1255344A1 publication Critical patent/HK1255344A1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
HK18114481.7A 2015-09-18 2018-11-13 Method for predicting prognosis and risk of developing hepatocellular carcinoma in liver cirrhosis patient HK1255344A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2015186067 2015-09-18
PCT/JP2016/077683 WO2017047813A1 (en) 2015-09-18 2016-09-20 Method for predicting prognosis and risk of developing hepatocellular carcinoma in liver cirrhosis patient

Publications (1)

Publication Number Publication Date
HK1255344A1 true HK1255344A1 (en) 2019-08-16

Family

ID=58289436

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18114481.7A HK1255344A1 (en) 2015-09-18 2018-11-13 Method for predicting prognosis and risk of developing hepatocellular carcinoma in liver cirrhosis patient

Country Status (4)

Country Link
JP (1) JP6779504B2 (en)
CN (1) CN108351359B (en)
HK (1) HK1255344A1 (en)
WO (1) WO2017047813A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11713458B2 (en) * 2016-06-20 2023-08-01 Octapharma Ag Means and methods for modifying multiple alleles
WO2020175672A1 (en) * 2019-02-28 2020-09-03 シスメックス株式会社 Method for detecting target substance, reagent for detecting target substance, and reagent kit for detecting target substance
CN111381033B (en) * 2020-01-19 2023-03-24 深圳格道糖生物技术有限公司 Application of specific lectin combination in construction of test tool for identifying ultra-early liver cancer based on salivary glycoprotein carbohydrate chain
CN113484517B (en) * 2021-07-05 2024-06-25 川北医学院附属医院 Biomarker for diagnosing early hepatocellular carcinoma and construction method of diagnosis mode
CN113721029B (en) * 2021-08-25 2023-06-06 西北大学 Testing tool and system for identifying liver cirrhosis and liver cancer by specific lectin combination

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011007764A1 (en) * 2009-07-14 2011-01-20 独立行政法人産業技術総合研究所 Sugar chain marker as measure of disease conditions of hepatic diseases
EP2479577A1 (en) * 2009-09-18 2012-07-25 Mitsubishi Chemical Corporation Hepatocellular carcinoma marker
CN103221419B (en) * 2010-09-17 2015-12-09 独立行政法人产业技术综合研究所 Lung cancer identification marker

Also Published As

Publication number Publication date
JP6779504B2 (en) 2020-11-04
CN108351359A (en) 2018-07-31
WO2017047813A1 (en) 2017-03-23
JPWO2017047813A1 (en) 2018-07-26
CN108351359B (en) 2021-04-23

Similar Documents

Publication Publication Date Title
HK1255344A1 (en) Method for predicting prognosis and risk of developing hepatocellular carcinoma in liver cirrhosis patient
MA41237A (en) NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS
EP2986324A4 (en) Compositions and methods for detection and treatment of hepatocellular carcinoma
GB201516433D0 (en) Computer apparatus and method for enhancing clinical pathways
EP3674405A4 (en) Method for assessing risk of hepatocellular carcinoma
IL281752A (en) Novel peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (hcc) and other cancers
GB201617722D0 (en) Method for determining prognosis of cancer
ZA201407879B (en) Method for diagnosing hepatocellular carcinoma (hcc)